Giacomo d’Andrea

1.1k total citations
40 papers, 418 citations indexed

About

Giacomo d’Andrea is a scholar working on Pharmacology, Psychiatry and Mental health and Clinical Psychology. According to data from OpenAlex, Giacomo d’Andrea has authored 40 papers receiving a total of 418 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pharmacology, 13 papers in Psychiatry and Mental health and 12 papers in Clinical Psychology. Recurrent topics in Giacomo d’Andrea's work include Treatment of Major Depression (18 papers), Tryptophan and brain disorders (10 papers) and Bipolar Disorder and Treatment (8 papers). Giacomo d’Andrea is often cited by papers focused on Treatment of Major Depression (18 papers), Tryptophan and brain disorders (10 papers) and Bipolar Disorder and Treatment (8 papers). Giacomo d’Andrea collaborates with scholars based in Italy, United Kingdom and United States. Giacomo d’Andrea's co-authors include Giovanni Martinotti, Mauro Pettorruso, Andrea Miuli, Roger S. McIntyre, Stefania Chiappini, Stefano L. Sensi, Francesco Di Carlo, Massimo di Giannantonio, Giorgio Di Lorenzo and Alessio Mosca and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Molecular Cell.

In The Last Decade

Giacomo d’Andrea

35 papers receiving 414 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Giacomo d’Andrea Italy	12	187	144	112	105	74	40	418
Charli Randolph United States	3	161 0.9×	137 1.0×	96 0.9×	105 1.0×	41 0.6×	5	392
Madeeha Nasir United States	8	98 0.5×	110 0.8×	86 0.8×	106 1.0×	52 0.7×	13	397
Alzbeta Juven‐Wetzler Israel	15	129 0.7×	279 1.9×	131 1.2×	128 1.2×	97 1.3×	23	620
Xiaoyin Ke China	11	112 0.6×	69 0.5×	109 1.0×	56 0.5×	64 0.9×	16	356
Nancy B. Lundin United States	11	130 0.7×	77 0.5×	112 1.0×	149 1.4×	81 1.1×	28	399
A Ricciardi United Kingdom	9	155 0.8×	137 1.0×	86 0.8×	100 1.0×	183 2.5×	14	509
Yazen Alnefeesi Canada	7	116 0.6×	81 0.6×	105 0.9×	64 0.6×	57 0.8×	10	304
Lejla Čolić Germany	14	176 0.9×	102 0.7×	133 1.2×	113 1.1×	113 1.5×	45	583
Mikael Tiger Sweden	13	159 0.9×	61 0.4×	85 0.8×	103 1.0×	161 2.2×	31	464
Marie‐Josée Filteau Canada	6	228 1.2×	68 0.5×	123 1.1×	190 1.8×	78 1.1×	7	539

Countries citing papers authored by Giacomo d’Andrea

Since Specialization

Citations

This map shows the geographic impact of Giacomo d’Andrea's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Giacomo d’Andrea with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Giacomo d’Andrea more than expected).

Fields of papers citing papers by Giacomo d’Andrea

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Giacomo d’Andrea. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Giacomo d’Andrea. The network helps show where Giacomo d’Andrea may publish in the future.

Co-authorship network of co-authors of Giacomo d’Andrea

This figure shows the co-authorship network connecting the top 25 collaborators of Giacomo d’Andrea. A scholar is included among the top collaborators of Giacomo d’Andrea based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Giacomo d’Andrea. Giacomo d’Andrea is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

d’Andrea, Giacomo, R Tucci, Alessio Mosca, et al.. (2025). Psychedelics and ketamine/esketamine in depressive disorders: biological mechanisms and associated neuroimaging and clinical changes. Translational Psychiatry. 15(1). 453–453.

Chiappini, Stefania, Andrea Miuli, Giacomo d’Andrea, et al.. (2025). Novel perspectives for glutamatergic strategies, psychedelics and antipsychotic augmentation in Treatment Resistant Depression: A narrative review. 1(1).

d’Andrea, Giacomo, Alessio Mosca, Francesco Di Carlo, et al.. (2025). PHARMACOVIGILANCE SIGNALS OF SEMAGLUTIDE AND OTHER GLP-1 RECEPTOR AGONISTS: AN ANALYSIS OF THE FOOD AND DRUG ADMINISTRATION (FDA) ADVERSE EVENTS REPORTING SYSTEM (FAERS) DATASET. The International Journal of Neuropsychopharmacology. 28(Supplement_1). i300–i300.

Rhee, Taeho Greg, Sung Ryul Shim, Kevin J. Manning, et al.. (2024). Neuropsychological Assessments of Cognitive Impairment in Major Depressive Disorder: A Systematic Review and Meta-Analysis with Meta-Regression. Psychotherapy and Psychosomatics. 93(1). 8–23. 22 indexed citations

Le, Gia Han, Angela T.H. Kwan, Sabrina Wong, et al.. (2024). Impact of elevated body mass index (BMI) on cognitive functioning and inflammation in persons with post-COVID-19 condition: a secondary analysis. Acta Neuropsychiatrica. 36(4). 211–217. 1 indexed citations

Pizzuto, Daniele Antonio, Fabrizio Cocciolillo, Federica Cavallo, et al.. (2024). Dopaminergic dysfunction in the left putamen of patients with major depressive disorder. Journal of Affective Disorders. 357. 107–115. 5 indexed citations

Chiappini, Stefania, Alessio Mosca, Andrea Miuli, et al.. (2024). New trends of drug abuse in custodial settings: A systematic review on the misuse of over-the-counter drugs, prescription-only-medications, and new psychoactive substances. Neuroscience & Biobehavioral Reviews. 162. 105691–105691. 19 indexed citations

Chiappini, Stefania, Alessio Mosca, Giacomo d’Andrea, et al.. (2024). Examining Lurasidone Efficacy in Patients with Schizophrenia Spectrum Illness and Concurrent Alcohol and Substance Use Disorder: A Prospective, Multicentric, Real-World Investigation. Journal of Clinical Medicine. 13(8). 2206–2206. 6 indexed citations

d’Andrea, Giacomo, Andrea Miuli, Mauro Pettorruso, et al.. (2024). Exploring vortioxetine combination with intranasal esketamine: A feasible alternative to SSRI/SNRI? - Insights from the REAL-ESK study. Journal of Affective Disorders. 367. 583–588. 1 indexed citations

10.

Jawad, Muhammad Youshay, et al.. (2023). The Role of Ketamine in the Treatment of Bipolar Depression: A Scoping Review. Brain Sciences. 13(6). 909–909. 11 indexed citations

11.

Le, Gia Han, Angela T.H. Kwan, Sabrina Wong, et al.. (2023). Impact of Elevated Body Mass Index (BMI) on Hedonic Tone in Persons with Post-COVID-19 Condition: A Secondary Analysis. Advances in Therapy. 41(2). 686–695. 2 indexed citations

12.

Chiappini, Stefania, Giacomo d’Andrea, Sergio De Filippis, et al.. (2023). Esketamine in treatment-resistant depression patients comorbid with substance-use disorder: A viewpoint on its safety and effectiveness in a subsample of patients from the REAL-ESK study. European Neuropsychopharmacology. 74. 15–21. 35 indexed citations

13.

Wu, Jie, Angela T.H. Kwan, Taeho Greg Rhee, et al.. (2023). A narrative review of non-racemic amisulpride (SEP-4199) for treatment of depressive symptoms in bipolar disorder and LB-102 for treatment of schizophrenia. Expert Review of Clinical Pharmacology. 16(11). 1085–1092. 3 indexed citations

14.

d’Andrea, Giacomo, Mauro Pettorruso, Giorgio Di Lorenzo, et al.. (2023). The rapid antidepressant effectiveness of repeated dose of intravenous ketamine and intranasal esketamine: A post-hoc analysis of pooled real-world data. Journal of Affective Disorders. 348. 314–322. 32 indexed citations

15.

Chiappini, Stefania, Alessio Mosca, Andrea Miuli, et al.. (2023). Aripiprazole once monthly as a maintenance treatment for patients with schizophrenia and alcohol/substance use disorder: an observational, real-world study. Advances in Dual Diagnosis. 16(3). 185–198. 1 indexed citations

16.

Chiappini, Stefania, Francesco Di Carlo, Alessio Mosca, et al.. (2023). Efficacy of Psychosocial and Psychological Interventions in Addition to Drug Therapy to Improve Global Functioning of Inpatients with Schizophrenia Spectrum and Mood Disorders: A Real-World Observational Study. Neuropsychiatric Disease and Treatment. Volume 19. 1887–1897. 5 indexed citations

17.

Miuli, Andrea, Mauro Pettorruso, Francesco Di Carlo, et al.. (2022). Impact of sleep disorders and disease duration on neurotrophins levels in cocaine use disorder. Neuroscience Letters. 786. 136805–136805. 6 indexed citations

18.

Martinotti, Giovanni, Stefania Chiappini, Mauro Pettorruso, et al.. (2021). Therapeutic Potentials of Ketamine and Esketamine in Obsessive–Compulsive Disorder (OCD), Substance Use Disorders (SUD) and Eating Disorders (ED): A Review of the Current Literature. Brain Sciences. 11(7). 856–856. 59 indexed citations

19.

Pettorruso, Mauro, Giacomo d’Andrea, Giovanni Martinotti, et al.. (2020). Hopelessness, Dissociative Symptoms, and Suicide Risk in Major Depressive Disorder: Clinical and Biological Correlates. Brain Sciences. 10(8). 519–519. 28 indexed citations

20.

Pettorruso, Mauro, Giulia Testa, Roser Granero, et al.. (2020). The transition time to gambling disorder: The roles that age, gambling preference and personality traits play. Addictive Behaviors. 116. 106813–106813. 14 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact